Skip to content

Comparative clinical trial between intra-articular corticosteroid infiltration or microfragmented adipose tissue in knee osteoarthritis

Randomized, triple-blind, controlled study to evaluate the efficacy of intra-articular infiltration of microfragmented aspirate of autologous adipose tissue compared to intra-articular infiltration of corticosteroids in the treatment of knee osteoarthritis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-9bsf32r
Enrollment
Unknown
Registered
2022-04-27
Start date
2021-11-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

The work in question is a prospective, double-blind, randomized, controlled study carried out in a single research center. Patients meeting the inclusion criteria will be randomized to receive either

Sponsors

Instituto de Ortopedia e Traumatologia de Universidade de São Paulo
Lead Sponsor
Geistlich Pharma do Brasil
Collaborator

Eligibility

Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Knee Osteoarthritis.Absence of local or systemic infection.Absence of arthritis of rheumatologic origin.Clinical deformity (varus/valgus/flexo/recurvate)or radiographic 40 (kg/height in m2)

Exclusion criteria

Exclusion criteria: Loss to follow-up.Presence of serious/debilitating clinical condition.Presence of new orthopedic injuries relevant during the study period (severe joint trauma to the knee.fractures of the lower limb or new ligament injuries).death

Design outcomes

Primary

MeasureTime frame
It is expected to find an improvement in pain in patients with knee osteoarthritis undergoing the intervention in question. For this, the Womac-A questionnaire, a subdivision of the Womac questionnaire, is used. Derived from WOMAC, with a score from 0 to 20, this subdivision includes only pain-related items. The difference between the post-intervention scores and the initial scores of both the group undergoing intervention with microfragmented adipose tissue and the control group will be compared

Secondary

MeasureTime frame
It is expected to find as a secondary outcome, an improvement in patients with knee osteoarthritis undergoing the intervention in question in the following categories: pain, joint stiffness and physical activity. For this, the Womac questionnaire is used. The difference between the post-intervention scores and the initial scores of both the group undergoing intervention with microfragmented adipose tissue and the control group will be compared;It is expected to find as a secondary outcome, an improvement in patients with knee osteoarthritis submitted to the intervention in question in the questions: specific symptoms of the knee. For this, the KOOS questionnaire is used. The difference between the post-intervention scores and the initial scores of both the group undergoing intervention with microfragmented adipose tissue and the control group will be compared;It is expected to find as a secondary outcome, an improvement in patients with knee osteoarthritis undergoing intervention in terms of quality of life. For this, the Eq-5D questionnaire is used, which encompasses 5 health domains (mobility, personal care, usual activities, pain/discomfort and anxiety/depression). The difference between the post-intervention scores and the initial scores of both the group undergoing intervention with microfragmented adipose tissue and the control group will be compared;It is expected to find as a secondary outcome, an improvement in the visual pain scale in patients with knee osteoarthritis undergoing the intervention. For this, a visual analog scale is applied (VAS), from 0 (no pain) to 10 (worst pain in life). The difference between the post-intervention scores and the initial scores of both the group undergoing intervention with microfragmented adipose tissue and the control group will be compared;It is expected to find as a secondary outcome, an improvement in range of motion in patients with knee osteoarthritis undergoing the intervention. For this, the measurement is a

Countries

Brazil

Contacts

Public ContactBruno Varone

Instituto de Ortopedia e Traumatologia de Universidade de São Paulo

brunobutturivarone@yahoo.com.br+55(011)972253360

Outcome results

None listed

Source: REBEC (via WHO ICTRP)